<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Gut Microbiome Interactions in Primary Sclerosing Cholangitis

Abstract

Primary sclerosing cholangitis (PSC) is a rare, progressive immune-mediated cholangiopathy with substantial risks of liver failure, colorectal neoplasia, and cholangiocarcinoma. This thesis examines evidence that genetic susceptibility, intestinal dysbiosis, barrier dysfunction, immune activation, and altered bile-acid signalling interact within a self-reinforcing gut-liver axis. PSC-associated dysbiosis is characterized by reduced microbial diversity, enrichment of pathobionts, depletion of SCFA-producing bacteria, and altered microbial metabolic functions. Impaired intestinal-barrier integrity may permit microbial products to reach the liver and activate inflammatory pathways in immune cells and cholangiocytes, promoting periductal fibrosis. Microbiome- and bile-acid-directed treatments have shown preliminary benefits, but none has demonstrated sustained improvement in transplant-free survival or disease prevention. Future progress requires longitudinal multiomic studies and rigorous clinical trials using appropriately stratified patients and clinically meaningful endpoints.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

Hozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.